Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...

The food and beverage industry is increasingly adopting the use of artificial intelligence (AI) in the development and scale ...

Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...

Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...

The Netherlands-based Ofichem Group signed a definitive agreement to acquire Avivia, another Netherlands-based company that specializes in formulation development. Ofichem officials say the ...

TAMPA, Fla.--(BUSINESS WIRE)--Xcelience, a leader in early drug development services, recently announced the addition of Brett F. Truitt, who will serve as Team Leader, Formulation Development in the ...

The aim of any formulation scientist is to create a product that is safe, effective, stable, and distinct from competitor drugs. It also helps if the product is as patient friendly as possible to ...

Quotient Sciences has announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a landmark achievement highlighting the ...

Industry experts discuss the benefits of utilizing contract development and contract research organizations in drug discovery and development. Drug discovery can involve extensive research to identify ...

Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit - the largest global meeting dedicated purely to LNPs. The official event guide is your ...

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...